Exploring and exploiting the aberrant DNA methylation profile of endocrine-resistant breast cancer

Epigenomics. 2013 Dec;5(6):595-8. doi: 10.2217/epi.13.70.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Biomarkers, Tumor
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • DNA Methylation*
  • Drug Resistance, Neoplasm / genetics*
  • Female
  • Genes, bcl-2
  • Humans
  • Pathology, Molecular

Substances

  • Antineoplastic Agents, Hormonal
  • Biomarkers, Tumor